Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Kian Behbakht

Concepts (457)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Ovarian Neoplasms
48
2025
586
5.510
 Why?
Poly(ADP-ribose) Polymerase Inhibitors
11
2025
132
1.590
 Why?
Endometrial Neoplasms
11
2025
208
1.140
 Why?
Peritoneal Neoplasms
7
2024
103
1.040
 Why?
Drug Resistance, Neoplasm
17
2024
881
1.020
 Why?
Cystadenocarcinoma, Serous
7
2025
84
0.990
 Why?
Genital Neoplasms, Female
6
2020
99
0.850
 Why?
Uterine Cervical Neoplasms
8
2017
267
0.840
 Why?
Antineoplastic Combined Chemotherapy Protocols
9
2020
1953
0.830
 Why?
Claudin-4
5
2025
17
0.760
 Why?
Biomarkers, Tumor
9
2025
1313
0.710
 Why?
Hysterectomy
4
2018
137
0.700
 Why?
Antineoplastic Agents
10
2023
2192
0.690
 Why?
Neoplasm Recurrence, Local
8
2025
1137
0.680
 Why?
Fallopian Tube Neoplasms
6
2024
19
0.680
 Why?
TNF-Related Apoptosis-Inducing Ligand
5
2017
54
0.620
 Why?
Gelatin
2
2016
56
0.570
 Why?
Neoplasms, Glandular and Epithelial
3
2015
49
0.550
 Why?
Thrombin
2
2016
165
0.540
 Why?
Models, Economic
1
2018
62
0.540
 Why?
Cell Line, Tumor
22
2025
3539
0.530
 Why?
Hyperthermia, Induced
1
2018
121
0.520
 Why?
Histone-Lysine N-Methyltransferase
3
2024
141
0.510
 Why?
Female
89
2025
77976
0.500
 Why?
Pelvic Infection
1
2016
6
0.490
 Why?
Homeodomain Proteins
3
2012
523
0.480
 Why?
Tissue Adhesives
1
2016
22
0.480
 Why?
Cost-Benefit Analysis
1
2018
623
0.450
 Why?
Neoplastic Cells, Circulating
2
2017
81
0.450
 Why?
Women
1
2015
50
0.430
 Why?
Genomic Instability
2
2025
66
0.430
 Why?
Sirolimus
2
2016
281
0.410
 Why?
Vagina
6
2016
201
0.390
 Why?
Humans
93
2025
144261
0.360
 Why?
Antibodies, Neoplasm
1
2012
34
0.360
 Why?
Middle Aged
50
2025
35762
0.360
 Why?
Health Knowledge, Attitudes, Practice
2
2015
1409
0.350
 Why?
Neoplasm Staging
15
2024
1461
0.350
 Why?
Cisplatin
2
2015
334
0.340
 Why?
Aged
38
2025
25850
0.330
 Why?
Aged, 80 and over
19
2025
8243
0.320
 Why?
Tumor Microenvironment
3
2025
732
0.320
 Why?
Apoptosis
8
2019
2430
0.310
 Why?
Pelvic Exenteration
1
2009
12
0.300
 Why?
Uterine Neoplasms
4
2019
96
0.300
 Why?
Leiomyosarcoma
3
2020
28
0.300
 Why?
Neoadjuvant Therapy
4
2020
462
0.290
 Why?
Receptors, TNF-Related Apoptosis-Inducing Ligand
3
2017
31
0.290
 Why?
Paclitaxel
3
2019
255
0.290
 Why?
Cytoreduction Surgical Procedures
2
2020
67
0.290
 Why?
Phthalazines
2
2019
64
0.290
 Why?
Robotic Surgical Procedures
3
2016
182
0.280
 Why?
Pyrimidines
3
2019
532
0.280
 Why?
Carcinoma, Endometrioid
3
2019
51
0.280
 Why?
Health Personnel
1
2015
742
0.280
 Why?
Carbazoles
1
2008
56
0.270
 Why?
Chemotherapy, Adjuvant
2
2020
419
0.270
 Why?
Caffeine
1
2008
74
0.270
 Why?
Gene Expression Regulation, Neoplastic
8
2025
1455
0.270
 Why?
Azepines
2
2019
107
0.260
 Why?
Papanicolaou Test
2
2004
35
0.260
 Why?
Vaginal Smears
2
2004
55
0.260
 Why?
Protein Kinase C
1
2008
252
0.250
 Why?
Adult
32
2025
40262
0.250
 Why?
Piperazines
2
2019
380
0.250
 Why?
Clinical Competence
1
2015
1241
0.250
 Why?
Postoperative Complications
6
2020
2916
0.230
 Why?
Hemostasis, Surgical
2
2016
27
0.230
 Why?
Tumor Escape
1
2025
49
0.230
 Why?
Immune Evasion
1
2025
64
0.220
 Why?
Laparotomy
2
2015
112
0.220
 Why?
Urban Health
1
2004
95
0.210
 Why?
Adenocarcinoma
4
2015
927
0.210
 Why?
Disease-Free Survival
7
2017
768
0.210
 Why?
Fallopian Tubes
1
2024
33
0.200
 Why?
Histocompatibility Antigens
2
2024
102
0.200
 Why?
Indoles
2
2025
501
0.200
 Why?
Genetic Therapy
2
2014
313
0.190
 Why?
Prognosis
9
2024
4278
0.190
 Why?
Pyrazoles
2
2020
509
0.190
 Why?
Uterine Cervical Dysplasia
2
2003
27
0.190
 Why?
Lipids
2
2025
700
0.180
 Why?
Adenocarcinoma, Clear Cell
2
2021
14
0.180
 Why?
Neoplasm Grading
5
2024
307
0.180
 Why?
Leiomyoma
2
2019
59
0.180
 Why?
Radiosurgery
1
2025
400
0.170
 Why?
Hospitals, Public
1
2001
29
0.170
 Why?
Piperidines
2
2019
217
0.170
 Why?
BRCA2 Protein
3
2019
67
0.160
 Why?
Hospitals, University
1
2001
176
0.160
 Why?
Vulvar Neoplasms
1
2020
13
0.160
 Why?
Healthcare Disparities
2
2018
725
0.160
 Why?
Cervix Uteri
3
2011
50
0.160
 Why?
Early Detection of Cancer
1
2025
462
0.160
 Why?
Epoxy Compounds
1
2020
32
0.160
 Why?
Mutation
5
2019
4085
0.150
 Why?
Carnitine O-Palmitoyltransferase
1
2020
49
0.150
 Why?
Treatment Outcome
11
2020
11643
0.150
 Why?
Rad51 Recombinase
1
2019
15
0.150
 Why?
Vaccines, Conjugate
1
2019
60
0.150
 Why?
Up-Regulation
2
2020
851
0.150
 Why?
Cell Movement
2
2016
965
0.150
 Why?
Enoxaparin
1
2020
67
0.150
 Why?
Machine Learning
1
2025
585
0.150
 Why?
Receptors, Adiponectin
1
2019
22
0.150
 Why?
Poly(ADP-ribose) Polymerases
1
2019
86
0.140
 Why?
Interleukin-12
2
2014
117
0.140
 Why?
Animals
15
2025
38030
0.140
 Why?
Sequence Analysis, RNA
2
2019
442
0.140
 Why?
Neoplasms
4
2017
2870
0.140
 Why?
Pyridones
1
2020
198
0.140
 Why?
CD8-Positive T-Lymphocytes
1
2024
917
0.140
 Why?
Lymph Node Excision
2
2020
173
0.140
 Why?
Cancer Vaccines
1
2019
160
0.140
 Why?
Mice
11
2025
18329
0.140
 Why?
Adjuvants, Immunologic
1
2019
245
0.140
 Why?
Cost Savings
1
2018
86
0.140
 Why?
Ovariectomy
2
2015
162
0.140
 Why?
Cell Growth Processes
2
2008
50
0.130
 Why?
Oncologists
1
2018
46
0.130
 Why?
Patient Acceptance of Health Care
1
2004
878
0.130
 Why?
Sarcoma
1
2020
205
0.130
 Why?
Dose-Response Relationship, Drug
4
2008
2026
0.130
 Why?
Antineoplastic Agents, Phytogenic
1
2019
177
0.130
 Why?
Aurora Kinase A
1
2017
62
0.130
 Why?
Pregnancy Complications, Infectious
1
2002
422
0.130
 Why?
Leukocyte Common Antigens
1
2017
88
0.130
 Why?
Anion Transport Proteins
1
2017
8
0.130
 Why?
Breast Neoplasms
4
2019
2447
0.130
 Why?
Salpingectomy
2
2015
15
0.130
 Why?
Sexual Dysfunctions, Psychological
1
2017
30
0.130
 Why?
Curettage
1
2016
8
0.130
 Why?
Fatty Acids
1
2020
450
0.130
 Why?
Gestational Trophoblastic Disease
1
2016
6
0.120
 Why?
beta Catenin
1
2019
252
0.120
 Why?
Keratins
1
2017
172
0.120
 Why?
Survival Rate
5
2020
2088
0.120
 Why?
Megestrol Acetate
1
2016
3
0.120
 Why?
Minority Groups
1
2018
277
0.120
 Why?
Carcinoma, Neuroendocrine
1
2016
35
0.120
 Why?
Neoplasms, Squamous Cell
1
1996
4
0.120
 Why?
Sexual Dysfunction, Physiological
1
2017
74
0.120
 Why?
Colony Count, Microbial
1
2016
122
0.120
 Why?
Gynecology
1
2018
178
0.120
 Why?
Standard of Care
1
2016
80
0.120
 Why?
Risk Factors
6
2016
10699
0.120
 Why?
Medroxyprogesterone Acetate
1
2015
37
0.120
 Why?
Adenoviridae
1
1996
199
0.120
 Why?
Venous Thromboembolism
1
2020
324
0.120
 Why?
Cell Survival
4
2025
1098
0.120
 Why?
Brachytherapy
1
2016
134
0.110
 Why?
Keratin-5
1
2015
48
0.110
 Why?
Gene Expression Profiling
2
2019
1782
0.110
 Why?
Molecular Targeted Therapy
1
2018
431
0.110
 Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2017
981
0.110
 Why?
Tretinoin
1
1996
124
0.110
 Why?
Immunohistochemistry
3
2016
1715
0.110
 Why?
Tamoxifen
1
2016
217
0.110
 Why?
Chemoradiotherapy
1
2016
237
0.110
 Why?
Anticoagulants
1
2020
721
0.110
 Why?
Combined Modality Therapy
4
2020
1264
0.110
 Why?
Cell Proliferation
5
2024
2494
0.110
 Why?
CA-125 Antigen
2
2008
13
0.110
 Why?
Abdominal Abscess
1
2014
25
0.110
 Why?
Antineoplastic Agents, Hormonal
1
2015
194
0.110
 Why?
Mice, SCID
2
2012
369
0.100
 Why?
Xenograft Model Antitumor Assays
3
2024
928
0.100
 Why?
Cytokines
1
2002
2061
0.100
 Why?
Endometrium
1
2014
61
0.100
 Why?
Kaplan-Meier Estimate
4
2020
964
0.100
 Why?
Glycoproteins
1
2015
355
0.100
 Why?
Surgeons
1
2018
338
0.100
 Why?
Interpersonal Relations
1
2017
399
0.100
 Why?
Lipid Metabolism
1
2017
525
0.100
 Why?
Cell Cycle
2
2025
596
0.100
 Why?
Immunotherapy
1
2018
652
0.100
 Why?
Case-Control Studies
5
2025
3592
0.100
 Why?
Double-Blind Method
4
2025
2025
0.100
 Why?
Reoperation
1
2016
629
0.100
 Why?
Quality of Health Care
1
2018
688
0.100
 Why?
Proto-Oncogene Proteins c-akt
2
2016
436
0.100
 Why?
Transforming Growth Factor beta
1
1996
479
0.100
 Why?
Pelvic Neoplasms
1
2013
24
0.100
 Why?
Genes, Tumor Suppressor
3
1998
82
0.100
 Why?
Plasmids
1
2014
379
0.100
 Why?
Models, Biological
3
2019
1820
0.090
 Why?
Antigens, CD
1
2015
555
0.090
 Why?
Young Adult
5
2020
13990
0.090
 Why?
Gardnerella vaginalis
2
2002
3
0.090
 Why?
Cell Division
2
2008
766
0.090
 Why?
Antibody Specificity
1
2012
181
0.090
 Why?
Neoplastic Stem Cells
1
2015
412
0.090
 Why?
Endocrine Gland Neoplasms
1
2011
1
0.090
 Why?
Transplantation, Heterologous
1
2012
193
0.090
 Why?
RNA, Messenger
2
2012
2829
0.090
 Why?
Escherichia coli
1
2016
852
0.090
 Why?
RNA, Small Interfering
3
2020
634
0.090
 Why?
Cyclin D1
1
2011
61
0.090
 Why?
Drug Synergism
2
2011
357
0.080
 Why?
Proteasome Inhibitors
1
2011
40
0.080
 Why?
MicroRNAs
1
2017
700
0.080
 Why?
DNA
1
2017
1460
0.080
 Why?
Adenocarcinoma, Mucinous
1
2011
76
0.080
 Why?
Transfection
2
2007
938
0.080
 Why?
Cadherins
1
2011
200
0.080
 Why?
Peptides
1
2015
995
0.080
 Why?
Neoplasm Invasiveness
3
2016
508
0.080
 Why?
Age Factors
5
2016
3313
0.070
 Why?
Lymphoma
1
2011
232
0.070
 Why?
Skin Transplantation
1
2009
85
0.070
 Why?
Inflammation
1
2020
2877
0.070
 Why?
Anastomosis, Surgical
1
2009
157
0.070
 Why?
Urokinase-Type Plasminogen Activator
1
2008
24
0.070
 Why?
Papillomaviridae
2
2002
115
0.070
 Why?
Adaptor Proteins, Signal Transducing
1
2011
427
0.070
 Why?
G2 Phase
1
2008
39
0.070
 Why?
Adolescent
5
2020
22281
0.070
 Why?
Radiation-Protective Agents
1
2008
17
0.070
 Why?
Rectum
1
2009
180
0.070
 Why?
TOR Serine-Threonine Kinases
1
2011
449
0.070
 Why?
Heterografts
2
2019
143
0.070
 Why?
Genes, BRCA1
2
1998
45
0.060
 Why?
Models, Statistical
1
2011
677
0.060
 Why?
Microsatellite Instability
2
2019
54
0.060
 Why?
Class I Phosphatidylinositol 3-Kinases
2
2019
108
0.060
 Why?
Urinary Bladder
1
2009
194
0.060
 Why?
Cell Culture Techniques
2
2020
375
0.060
 Why?
Cysteine
1
2008
210
0.060
 Why?
Tumor Suppressor Protein p53
3
2019
529
0.060
 Why?
PTEN Phosphohydrolase
2
2019
164
0.060
 Why?
Gynecologic Surgical Procedures
2
2020
64
0.060
 Why?
Models, Animal
1
2008
392
0.060
 Why?
Adenosarcoma
2
2005
2
0.060
 Why?
Proportional Hazards Models
3
2020
1322
0.060
 Why?
Follow-Up Studies
4
2020
5389
0.060
 Why?
Indazoles
2
2019
80
0.060
 Why?
Signal Transduction
4
2012
5221
0.060
 Why?
Polymerase Chain Reaction
4
2002
1054
0.060
 Why?
Colposcopy
2
2003
18
0.060
 Why?
Maintenance Chemotherapy
1
2025
42
0.060
 Why?
Intestinal Neoplasms
1
2005
30
0.060
 Why?
Cell Count
2
2015
320
0.060
 Why?
Ovary
1
2007
228
0.060
 Why?
Neoplasm Proteins
3
1998
442
0.060
 Why?
Length of Stay
3
2015
1335
0.060
 Why?
Retrospective Studies
6
2020
17009
0.060
 Why?
Sexual Behavior
1
2009
484
0.060
 Why?
Ultraviolet Rays
1
2008
387
0.060
 Why?
Germ-Line Mutation
2
1996
172
0.060
 Why?
Chicago
1
2004
61
0.050
 Why?
Tumor Cells, Cultured
2
1996
919
0.050
 Why?
Peptide Fragments
1
2008
698
0.050
 Why?
Disease Progression
3
2019
2840
0.050
 Why?
United States
5
2022
15876
0.050
 Why?
Antioxidants
1
2008
549
0.050
 Why?
Transcription Factors
4
2011
1739
0.050
 Why?
Blood Loss, Surgical
2
2015
112
0.050
 Why?
Survival Analysis
4
2020
1382
0.050
 Why?
Activating Transcription Factor 6
1
2023
21
0.050
 Why?
Transcription Factor AP-1
1
2023
79
0.050
 Why?
Receptors, Estrogen
2
2015
457
0.050
 Why?
X-ray Repair Cross Complementing Protein 1
1
2022
13
0.050
 Why?
Women's Health
1
2004
308
0.050
 Why?
Neoplasm Metastasis
2
2015
688
0.050
 Why?
Trichomonas vaginalis
1
2002
11
0.040
 Why?
Gene Expression
1
2007
1487
0.040
 Why?
Vaginal Neoplasms
1
2001
19
0.040
 Why?
Yeasts
1
2002
52
0.040
 Why?
Vaginosis, Bacterial
1
2001
10
0.040
 Why?
Vaginal Diseases
1
2001
18
0.040
 Why?
Phosphatidylinositol 3-Kinases
2
2016
379
0.040
 Why?
Risk Assessment
3
2016
3637
0.040
 Why?
Medical Oncology
1
2024
331
0.040
 Why?
Cell Nucleus
1
2025
618
0.040
 Why?
Endometriosis
1
2001
57
0.040
 Why?
DNA, Neoplasm
2
1998
163
0.040
 Why?
DNA Primers
1
2002
511
0.040
 Why?
Vulvectomy
1
2020
2
0.040
 Why?
Dermatofibrosarcoma
1
2020
7
0.040
 Why?
Histiocytoma, Malignant Fibrous
1
2020
5
0.040
 Why?
Pregnancy
3
2016
7180
0.040
 Why?
Epithelial Cells
1
2007
1125
0.040
 Why?
Quality of Life
2
2025
3166
0.040
 Why?
Hospitals, Urban
1
2001
144
0.040
 Why?
Clinical Trials, Phase I as Topic
1
2020
52
0.040
 Why?
Medically Uninsured
1
2001
129
0.040
 Why?
Liposarcoma
1
2020
31
0.040
 Why?
Alleles
3
2017
878
0.040
 Why?
Anoikis
1
2020
30
0.040
 Why?
Databases, Factual
2
2016
1484
0.040
 Why?
Disease Models, Animal
2
2024
4556
0.040
 Why?
Hemocyanins
1
2019
61
0.040
 Why?
Interleukin-10
1
2002
309
0.040
 Why?
Rhabdomyosarcoma
1
2020
64
0.040
 Why?
Diagnosis, Differential
2
2019
1487
0.040
 Why?
Chitinase-3-Like Protein 1
1
2019
18
0.040
 Why?
DNA Repair
1
2022
255
0.040
 Why?
Enzyme-Linked Immunosorbent Assay
1
2002
850
0.040
 Why?
Logistic Models
1
2004
2104
0.040
 Why?
Prospective Studies
4
2016
7970
0.040
 Why?
Neoplasms, Cystic, Mucinous, and Serous
1
2019
28
0.040
 Why?
SEER Program
1
2020
224
0.040
 Why?
Intramolecular Oxidoreductases
1
2019
66
0.040
 Why?
Radiotherapy
1
2020
206
0.040
 Why?
DNA Polymerase II
1
2019
35
0.040
 Why?
Poly-ADP-Ribose Binding Proteins
1
2019
36
0.040
 Why?
Lymphatic Metastasis
1
2020
333
0.040
 Why?
DNA Damage
1
2022
428
0.040
 Why?
Gene Knockdown Techniques
1
2020
336
0.040
 Why?
Chromosomes, Human, Pair 7
1
1998
17
0.040
 Why?
Cell Cycle Checkpoints
1
2019
99
0.040
 Why?
Cytoskeletal Proteins
1
2019
156
0.040
 Why?
Mechanistic Target of Rapamycin Complex 1
1
2019
139
0.040
 Why?
Microtubule-Associated Proteins
1
2019
196
0.030
 Why?
Mitosis
1
2019
199
0.030
 Why?
Interleukin-1
1
2002
961
0.030
 Why?
AMP-Activated Protein Kinases
1
2019
190
0.030
 Why?
Europe
1
2019
412
0.030
 Why?
Colorectal Neoplasms, Hereditary Nonpolyposis
1
1998
40
0.030
 Why?
Image Cytometry
1
2017
12
0.030
 Why?
Interleukin-6
1
2002
780
0.030
 Why?
Chromosomes, Human, Pair 14
1
1997
21
0.030
 Why?
Wnt Signaling Pathway
1
2019
210
0.030
 Why?
Ganciclovir
1
1996
53
0.030
 Why?
Chromosome Deletion
1
1997
124
0.030
 Why?
Hospitals, Private
1
2016
12
0.030
 Why?
Health Facility Size
1
2016
13
0.030
 Why?
Socioeconomic Factors
1
2001
1312
0.030
 Why?
Chorionic Gonadotropin
1
2016
77
0.030
 Why?
Mass Spectrometry
1
2019
744
0.030
 Why?
Cell Separation
1
2017
307
0.030
 Why?
Oxidation-Reduction
1
2020
1084
0.030
 Why?
Ifosfamide
1
1996
38
0.030
 Why?
AC133 Antigen
1
2015
20
0.030
 Why?
Cell Line, Transformed
1
1996
140
0.030
 Why?
Tissue Array Analysis
1
2015
50
0.030
 Why?
Cell Differentiation
2
2011
2048
0.030
 Why?
Time Factors
2
2019
7155
0.030
 Why?
Hospital Charges
1
1996
46
0.030
 Why?
Hospitals, Teaching
1
2016
119
0.030
 Why?
Marriage
1
2017
122
0.030
 Why?
Caspase 3
1
2016
238
0.030
 Why?
Cystadenocarcinoma, Papillary
1
1995
4
0.030
 Why?
Antigens, Neoplasm
1
2017
271
0.030
 Why?
Carboplatin
1
1996
160
0.030
 Why?
Tumor Burden
1
2016
319
0.030
 Why?
Ataxia Telangiectasia Mutated Proteins
1
2015
69
0.030
 Why?
Ileus
1
2015
13
0.030
 Why?
DNA Mismatch Repair
1
2015
52
0.030
 Why?
Genes, p53
1
1995
67
0.030
 Why?
RNA-Binding Proteins
1
2019
462
0.030
 Why?
Cell Cycle Proteins
1
2019
628
0.030
 Why?
Disease Management
1
2019
643
0.030
 Why?
Income
1
2016
199
0.030
 Why?
Urinary Retention
1
2015
25
0.030
 Why?
Female Urogenital Diseases
1
2014
7
0.030
 Why?
RNA Interference
1
2016
476
0.030
 Why?
Taxoids
1
2015
116
0.030
 Why?
Multivariate Analysis
2
1996
1533
0.030
 Why?
Morbidity
1
2015
323
0.030
 Why?
Receptors, Androgen
1
2015
153
0.030
 Why?
Drug Administration Schedule
1
2016
778
0.030
 Why?
Elective Surgical Procedures
1
2016
201
0.030
 Why?
Reference Values
1
1996
797
0.030
 Why?
Blood Volume
1
2014
65
0.030
 Why?
Sensitivity and Specificity
1
2019
1983
0.030
 Why?
Infusions, Parenteral
1
2014
41
0.030
 Why?
Intraoperative Complications
1
2015
155
0.030
 Why?
Bevacizumab
1
2015
167
0.030
 Why?
Polyethyleneimine
1
2014
18
0.030
 Why?
Point Mutation
1
1995
243
0.030
 Why?
Bleomycin
1
1996
253
0.030
 Why?
Histones
1
2019
668
0.030
 Why?
DNA, Viral
1
1996
358
0.030
 Why?
Hemostatics
1
2014
61
0.030
 Why?
Pelvis
1
2015
124
0.030
 Why?
Tumor Suppressor Proteins
1
2016
321
0.030
 Why?
Deoxycytidine
1
2015
221
0.030
 Why?
Receptors, Progesterone
1
2015
356
0.020
 Why?
Insurance, Health
1
2016
301
0.020
 Why?
Drainage
1
2014
185
0.020
 Why?
Anemia
1
2015
187
0.020
 Why?
Thrombocytopenia
1
2015
205
0.020
 Why?
Urban Population
1
2016
490
0.020
 Why?
Preoperative Care
1
2015
379
0.020
 Why?
Polymorphism, Single-Stranded Conformational
3
1998
26
0.020
 Why?
Gene Transfer Techniques
1
2014
185
0.020
 Why?
Patient Readmission
1
2018
756
0.020
 Why?
Membrane Proteins
1
2019
1165
0.020
 Why?
Ultrasonography
1
2016
768
0.020
 Why?
Biomarkers
1
2024
4254
0.020
 Why?
Linear Models
1
1994
850
0.020
 Why?
Referral and Consultation
1
2018
847
0.020
 Why?
Cholesterol
1
2014
399
0.020
 Why?
Analysis of Variance
1
1994
1304
0.020
 Why?
Zinc Finger E-box-Binding Homeobox 1
1
2011
23
0.020
 Why?
Perioperative Period
1
2011
71
0.020
 Why?
Mutant Proteins
1
2011
106
0.020
 Why?
DNA Fragmentation
1
2011
39
0.020
 Why?
Rural Population
1
2016
648
0.020
 Why?
Protein Kinase Inhibitors
1
2017
968
0.020
 Why?
Comorbidity
1
2016
1646
0.020
 Why?
Fas Ligand Protein
1
2011
60
0.020
 Why?
Risk Reduction Behavior
1
2013
225
0.020
 Why?
Hyperplasia
1
2011
174
0.020
 Why?
Neovascularization, Pathologic
1
2012
286
0.020
 Why?
Neoplasm Transplantation
1
2011
251
0.020
 Why?
Tomography, X-Ray Computed
2
2014
2730
0.020
 Why?
Polymorphism, Single Nucleotide
1
2017
2143
0.020
 Why?
Administration, Oral
1
2012
847
0.020
 Why?
Epithelial-Mesenchymal Transition
1
2011
219
0.020
 Why?
Regression Analysis
1
2011
998
0.020
 Why?
Polyethylene Glycols
1
2014
649
0.020
 Why?
Receptors, Urokinase Plasminogen Activator
1
2008
11
0.020
 Why?
Pregnancy Complications
1
2014
592
0.020
 Why?
Antibodies, Monoclonal, Humanized
1
2015
985
0.020
 Why?
Anti-Bacterial Agents
2
2014
1906
0.020
 Why?
Blotting, Western
1
2011
1187
0.020
 Why?
Injections, Subcutaneous
1
2008
164
0.020
 Why?
Placebos
1
2008
192
0.020
 Why?
Patient Discharge
1
2015
977
0.020
 Why?
Mice, Hairless
1
2008
47
0.020
 Why?
Enzyme Inhibitors
1
2011
824
0.020
 Why?
Sulfonamides
1
2011
580
0.020
 Why?
Molecular Sequence Data
3
1996
2929
0.020
 Why?
Quality Improvement
1
2015
1285
0.020
 Why?
Chromosome Mapping
2
1998
509
0.020
 Why?
Genetic Markers
2
1998
331
0.020
 Why?
Receptors, Cell Surface
1
2008
377
0.020
 Why?
Frameshift Mutation
2
1996
32
0.010
 Why?
Gene Deletion
2
1998
387
0.010
 Why?
Carcinosarcoma
1
2005
23
0.010
 Why?
Cross-Sectional Studies
1
2017
5813
0.010
 Why?
DNA Mutational Analysis
2
1996
405
0.010
 Why?
Cohort Studies
1
2015
5935
0.010
 Why?
Colorado
1
2014
4562
0.010
 Why?
Severity of Illness Index
1
2011
2917
0.010
 Why?
Obesity
1
2016
3057
0.010
 Why?
Base Sequence
2
1996
2187
0.010
 Why?
Electrophoresis, Gel, Pulsed-Field
1
2001
23
0.010
 Why?
Metronidazole
1
2001
20
0.010
 Why?
Genes, rRNA
1
2001
42
0.010
 Why?
Microbial Sensitivity Tests
1
2001
370
0.010
 Why?
DNA, Bacterial
1
2001
342
0.010
 Why?
RNA, Ribosomal, 16S
1
2001
558
0.010
 Why?
Loss of Heterozygosity
1
1998
52
0.010
 Why?
Microsatellite Repeats
1
1998
157
0.010
 Why?
Actuarial Analysis
1
1996
21
0.010
 Why?
Ecosystem
1
2001
589
0.010
 Why?
Genes, Neoplasm
1
1995
25
0.010
 Why?
BRCA1 Protein
1
1995
81
0.010
 Why?
Sequence Analysis, DNA
1
1998
824
0.010
 Why?
Age of Onset
1
1996
536
0.010
 Why?
Introns
1
1995
254
0.010
 Why?
Exons
1
1995
358
0.010
 Why?
Amino Acid Sequence
1
1995
2154
0.010
 Why?
Male
1
2017
72035
0.000
 Why?
Behbakht's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (457) concept(s)
_
Co-Authors Expand Description
See all (56) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)